Robert Flanagan is President of Clark Enterprises, Inc. (“CEI”), a privately held corporation with diverse assets in real estate, private equity and financial markets. Since 1989, Mr. Flanagan has spearheaded the expansion of CEI beyond construction and real estate, successfully launching CNF Investments, the private equity division of CEI that focuses on life sciences, oil and gas and technology investing. Mr. Flanagan currently serves on the boards of Eagle Oil & Gas Co., Brown Advisory, Svelte Medical Systems and is Chairman of the Board of Directors of Sagent Pharmaceuticals (NASDAQ:SGNT). He is Chairman of the Board of Directors of Washington’s Federal City Council, is a Trustee of Clark Charitable Foundation, and a member of the Board of Advisors of Georgetown University’s McDonough School of Business. Mr. Flanagan previously served on the Board of Directors of Clark Construction Group, LLC through 2015; was Chairman of the Board of Directors of Martek Biosciences Corporation (NASDAQ:MATK) and was Treasurer, Secretary and a member of the Board of Directors of Baltimore Orioles, Inc.
Mr. Flanagan received a BS in Business Administration from Georgetown University, an MST from the American University School of Business and is a Certified Public Accountant licensed in Washington, DC.